Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood. 2006;107:265–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR. US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin 2016;66:443–59.

Article  PubMed  Google Scholar 

Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(Jul):1720–48.

Article  PubMed  PubMed Central  Google Scholar 

Al-Mansour M, Connors JM, Gascoyne RD, Skinnider B, Savage KJ. Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin’s lymphoma. J Clin Oncol. 2010;28:793–9.

Article  PubMed  Google Scholar 

Biasoli I, Stamatoullas A, Meignin V, Delmer A, Reman O, Morschhauser F, et al. Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group. Cancer. 2010;116:631–9.

Article  PubMed  Google Scholar 

Hartmann S, Döring C, Jakobus C, Rengstl B, Newrzela S, Tousseyn T, et al. Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte Rich Large B Cell Lymphoma—Endpoints of a Spectrum of One Disease? PLoS One. 2013;8:e78812.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eyre TA, Gatter K, Collins GP, Hall GW, Watson C, Hatton CS. Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant Hodgkin lymphoma: Long-term outcomes from a 30-year experience. Am J Hematol. 2015;90:E103–E110.

Article  CAS  PubMed  Google Scholar 

Eichenauer DA, Plütschow A, Fuchs M, von Tresckow B, Böll B, Behringer K, et al. Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group. J Clin Oncol. 2015;33:2857–62.

Article  CAS  PubMed  Google Scholar 

Kenderian SS, Habermann TM, Macon WR, Ristow KM, Ansell SM, Colgan JP, et al. Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution. Blood. 2016;127:1960–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shankar AG, Roques G, Kirkwood AA, Lambilliotte A, Freund K, Leblanc T, et al. Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: Clinical characteristics and treatment outcome—A report from the SFCE & CCLG groups. Br J Haematol. 2017;177:106–15.

Article  CAS  PubMed  Google Scholar 

Marks LJ, Pei Q, Bush R, Buxton A, Appel B, Kelly KM, et al. Outcomes in intermediate-risk pediatric lymphocyte-predominant Hodgkin lymphoma: A report from the Children’s Oncology Group. Pediatr Blood Cancer. 2018;65:e27375.

Article  PubMed  PubMed Central  Google Scholar 

Binkley MS, Rauf MS, Milgrom SA, Pinnix CC, Tsang R, Dickinson M, et al. Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: A multi-institutional study of adult patients by ILROG. Blood. 2020;135:2365–74.

Article  PubMed  Google Scholar 

Eichenauer DA, Plütschow A, Fuchs M, Sasse S, Baues C, Böll B, et al. Long-Term Follow-Up of Patients with Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated in the HD7 to HD15 Trials: A Report From the German Hodgkin Study Group. J Clin Oncol. 2020;38:698–705.

Article  PubMed  Google Scholar 

Paschold L, Willscher E, Bein J, Vornanen M, Eichenauer DA, Simnica D, et al. Evolutionary clonal trajectories in nodular lymphocyte-predominant Hodgkin lymphoma with high risk of transformation. Haematologica. 2021;106:2654–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA. Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol. 2003;27:1346–56.

Article  PubMed  Google Scholar 

Hartmann S, Eichenauer DA, Plütschow A, Mottok A, Bob R, Koch K, et al. The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood. 2013;19:4246–52.

Article  Google Scholar 

Hartmann S, Eichenauer DA. Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell/histiocyte rich large B-cell lymphoma. Pathology. 2020;52:142–53.

Article  CAS  PubMed  Google Scholar 

Xia D, Sayed S, Moloo Z, Gakinya SM, Mutuiri A, Wawire J, et al. Geographic variability of nodular lymphocyte-predominant Hodgkin Lymphoma. Am J Clin Pathol. 2022;157:231–43.

Article  PubMed  Google Scholar 

El Weshi A, Akhtar S, Mourad WA, Ajarim D, Abdelsalm M, Khafaga Y, et al. T-cell/histiocyte-rich B-cell lymphoma: Clinical presentation, management and prognostic factors: Report on 61 patients and review of literature. Leuk Lymphoma. 2007;48:1764–73.

Article  PubMed  Google Scholar 

Bouabdallah R, Mounier N, Guettier C, Molina T, Ribrag V, Thieblemont C, et al. T-Cell/Histiocyte-Rich Large B-Cell Lymphomas and Classical Diffuse Large B-Cell Lymphomas Have Similar Outcome After Chemotherapy: A Matched-Control Analysis. J Clin Oncol. 2003;21:1271–7.

Article  CAS  PubMed  Google Scholar 

Franke S, Wlodarska I, Maes B, Vandenberghe P, Delabie J, Hagemeijer A, et al. Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances. Blood. 2001;97:1845–53.

Article  CAS  PubMed  Google Scholar 

Franke S, Wlodarska I, Maes B, Vandenberghe P, Achten R, Hagemeijer A, et al. Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich B-cell lymphoma from nodular lymphocyte predominance Hodgkin’s lymphoma. Am J Pathol. 2002;161:1861–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goltsev Y, Samusik N, Kennedy-Darling J, Bhate S, Hale M, Vazquez G, et al. Deep Profiling of Mouse Splenic Architecture With CODEX Multiplexed Imaging. Cell. 2018;174:968–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schürch CM, Bhate SS, Barlow GL, Phillips DJ, Noti L, Zlobec I, et al. Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front. Cell. 2020;182:1341–59.e19.

Article  PubMed  PubMed Central  Google Scholar 

Phillips D, Matusiak M, Gutierrez BR, Bhate SS, Barlow GL, Jiang S, et al. Immune Cell Topography Predicts Response to PD-1 Blockade in Cutaneous T Cell Lymphoma. Nat Commun. 2021;12:6721.

Article  Google Scholar 

Phillips D, Schürch CM, Khodadoust MS, Kim YH, Nolan GP, Jiang S. Highly Multiplexed Phenotyping of Immunoregulatory Proteins in the Tumor Microenvironment by CODEX Tissue Imaging. Front Immunol. 2021;12:687673.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brune V, Tiacci E, Pfeil I, Döring C, Eckerle S, van Noesel CJ, et al. Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med. 2008;205:2251–2268.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Du Z, Lin JR, Rashid R, Maliga Z, Wang S, Aster JC, et al. Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging. Nat Protoc. 2019;14:2900–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spidlen J, Moore W, Parks D, Goldberg M, Bray C, Bierre P, et al. Data File Standard for Flow Cytometry, version FCS 3.1. Cytom A. 2010;77:97–100.

Article  Google Scholar 

Satija R, Farrell JA, Gennert D, Schier AF, Regev A. Spatial reconstruction of single-cell gene expression data. Nat Biotechnol. 2015;33:495–502.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nature Biotechnol. 2018;36:411–20.

Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;177:1888–902.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang X, Tsang P. 196 IMP3/KOC1, a new immunohistochemical marker for differentiating classical Hodgkin Lymphoma and nodular lymphocyte predominant Hodgkin lymphoma from diffuse large B-Cell lymphoma. Am J Clin Pathol. 2018;149:S83–S84.

Article  Google Scholar 

Kosari F, Bakhshi T, Ameli F, Mokhtari M. The utility of IMP3 immunohistochemical staining in differentiating nodular lymphocyte predominant Hodgkin Lymphoma from T-Cell/Histiocyte-Rich large B-Cell lymphoma. BMC Cancer. 2022;22:1359.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Poppe B, De Paepe P, Michaux L, Dastugue N, Bastard C, Herens C, et al. PAX5/IGH rearrangement is a recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements. Genes Chromosomes Cancer. 2005;44:218–23.

Article  CAS  PubMed